NYU Langone Health
New York, 10016, United States
Location status: Recruiting
Location contact
Gadi Wollstein, MD
PRINCIPAL_INVESTIGATOR
Jamika Singleton-Garvin
CONTACT
NCT Number: NCT03400137
The purpose of this study is to improve understanding of the pathophysiologic process that leads to the development of glaucamotous damage. The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased intraocular pressure (IOP) is a major risk factor. It is also thought that the LC is a site of primary damage during pathogenesis of the disease. This prospective study with determine the in-vivo mechanical response to IOP modulation at the level of the ONH and LC.
Interested in participating?
Request Info18 year–90 year
All sexes
Interventional
Not applicable
New York, 10016, United States
Location status: Recruiting
Gadi Wollstein, MD
PRINCIPAL_INVESTIGATOR
Jamika Singleton-Garvin
CONTACT
The present study will briefly increase the pressure in eyes of living subjects and examine the effect of elevated intraocular pressure on optic nerve topography and position during pressure elevation using optical coherence tomography imaging of the posterior eye. Outcome measures will include measurements in microns based on these images quantifying the deformation of the lamina cribrosa.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Healthy volunteers
Glaucoma suspects
Glaucoma
Exclusion criteria
intraocular pressure will be increased using an ophthalmodynanometer
Time frame: 10 Minutes
OCT scanning will be obtained at baseline and with increased IOP. The IOP elevation will last no longer than two minutes, during which scans will be acquired by the imaging device.
Time frame: 10 Minutes
OCT scanning will be obtained at baseline and with increased IOP. The IOP elevation will last no longer than two minutes, during which scans will be acquired by the imaging device.
Time frame: 10 Minutes
OCT scanning will be obtained at baseline and with increased IOP. The IOP elevation will last no longer than two minutes, during which scans will be acquired by the imaging device.
Contact information is provided by the study sponsor or research team.
NYU Langone Health
Other
Effects of Elevated Intraocular Pressure on the Lamina Cribrosa
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06275308
Intraocular Pressure
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05716945
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases
Apeldoorn, Gelderland, Netherlands
View Trial DetailsNCT04628663
Intraocular Pressure
Athens, Attica, Greece
View Trial DetailsNCT06016712
Delivery, Eye Diseases
Prague, Czechia
View Trial Details